<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref135">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stachulski</surname>
    <given-names>A. V.</given-names>
   </name>
   <name>
    <surname>Santoro</surname>
    <given-names>M. G.</given-names>
   </name>
   <name>
    <surname>Piacentini</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Belardo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Frazia</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pidathala</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2018</year>). 
  <article-title>Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus</article-title>. 
  <source>Future Med. Chem.</source>
  <volume>10</volume>, 
  <fpage>851</fpage>â€“
  <lpage>862</lpage>. 
  <pub-id pub-id-type="doi">10.4155/fmc-2017-0217</pub-id>, PMID: 
  <?supplied-pmid 29629834?>
  <pub-id pub-id-type="pmid">29629834</pub-id>
 </mixed-citation>
</ref>
